We are live on ! Find out more
PFU

Parus Finance (UK) Portfolio holdings

AUM $383M
1-Year Est. Return 59.32%
This Fund
S&P 500
This Quarter Est. Return
+12.63%
1 Year Est. Return
+59.32%
3 Year Est. Return
+199.11%
5 Year Est. Return
+323.06%
10 Year Est. Return
+2,102.86%
AUM
$147M
AUM Growth
+$32M
Cap. Flow
+$23.8M
Cap. Flow %
16.17%
Top 10 Hldgs %
69.3%
Holding
28
New
1
Increased
6
Reduced
21
Closed

Top Buys

Rank Stock Value
1
SLB icon
SLB Ltd
SLB
+$6.23M
2
XOM icon
ExxonMobil
XOM
+$5.91M
3
CVX icon
Chevron
CVX
+$5.77M
4
TSLA icon
Tesla
TSLA
+$4.72M
5
HP icon
Helmerich & Payne
HP
+$3.66M

Top Sells

Rank Stock Value
1
SYF icon
Synchrony
SYF
+$1.46M
2
MSFT icon
Microsoft
MSFT
+$782K
3
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$411K
4
CVS icon
CVS Health
CVS
+$315K
5
ELV icon
Elevance Health
ELV
+$249K

Sector Composition

Rank Sector Weight
1 Healthcare 26.48%
2 Energy 23.44%
3 Technology 18.35%
4 Communication Services 16.98%
5 Consumer Discretionary 7.19%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MSFT icon
1
Microsoft
MSFT
$3.59T
$19.3M 13.11%
80,447
-3,260
-4% -$782K
META icon
2
Meta Platforms (Facebook)
META
$1.4T
$12.7M 8.65%
105,793
+11,159
+12% +$1.31M
SLB icon
3
SLB Ltd
SLB
$79.9B
$12.7M 8.6%
236,828
+125,202
+112% +$6.23M
GOOGL icon
4
Alphabet (Google) Class A
GOOGL
$4.22T
$10.2M 6.94%
115,793
-4,320
-4% -$411K
CVS icon
5
CVS Health
CVS
$119B
$9.7M 6.59%
104,037
-3,266
-3% -$315K
ELV icon
6
Elevance Health
ELV
$86.9B
$9.41M 6.39%
18,345
-490
-3% -$249K
XOM icon
7
ExxonMobil
XOM
$679B
$8.3M 5.64%
75,258
+55,142
+274% +$5.91M
CVX icon
8
Chevron
CVX
$403B
$7.68M 5.22%
42,807
+33,050
+339% +$5.77M
HUM icon
9
Humana
HUM
$45.5B
$6.15M 4.18%
12,008
-325
-3% -$171K
HP icon
10
Helmerich & Payne
HP
$4.35B
$5.85M 3.97%
118,000
+76,890
+187% +$3.66M
MRNA icon
11
Moderna
MRNA
$57.9B
$5.68M 3.86%
31,607
+4,740
+18% +$775K
LUV icon
12
Southwest Airlines
LUV
$19.8B
$5.55M 3.77%
164,792
-4,350
-3% -$157K
BNTX icon
13
BioNTech
BNTX
$29.3B
$4.5M 3.06%
29,988
-800
-3% -$123K
ORCL icon
14
Oracle
ORCL
$422B
$4.09M 2.78%
50,016
-1,080
-2% -$82.1K
TCOM icon
15
Trip.com Group
TCOM
$29B
$3.89M 2.65%
113,154
-5,495
-5% -$158K
SYF icon
16
Synchrony
SYF
$25.9B
$3.08M 2.09%
93,633
-42,679
-31% -$1.46M
TSLA icon
17
Tesla
TSLA
$1.43T
$3.07M 2.09%
+24,938
New +$4.72M
CI icon
18
Cigna
CI
$73.3B
$2.79M 1.9%
8,420
-340
-4% -$108K
ADBE icon
19
Adobe
ADBE
$109B
$2.3M 1.56%
6,842
-300
-4% -$95.9K
CRTO icon
20
Criteo S.A.
CRTO
$855M
$2.05M 1.39%
78,475
-3,270
-4% -$84.7K
BKNG icon
21
Booking.com
BKNG
$158B
$2.04M 1.39%
25,350
-1,000
-4% -$75.9K
NVDA icon
22
NVIDIA
NVDA
$5.2T
$1.32M 0.9%
90,490
-4,000
-4% -$58.7K
ALLY icon
23
Ally Financial
ALLY
$13.1B
$1.3M 0.88%
53,065
-2,390
-4% -$63.6K
PYPL icon
24
PayPal
PYPL
$52.7B
$1.19M 0.81%
16,688
-680
-4% -$54.4K
AMZN icon
25
Amazon
AMZN
$2.79T
$1.05M 0.71%
12,482
-490
-4% -$48.4K

Similar funds

Parus Finance (UK)'s Q4 2022 Portfolio in Review

As of Q4 2022, Parus Finance (UK) held 28 positions worth $147M, up 28% from $115M the previous quarter. Its ten largest holdings account for 69% of the portfolio.

Parus Finance (UK) deployed $23.8M of net new capital in Q4 2022, opening 1 new position and adding to 6 existing holdings. Its largest new stake was Tesla: 24,938 shares worth $3.07M.

By sector, the portfolio is most concentrated in Healthcare at 26% of assets, down from 31% a quarter earlier, followed by Energy and Technology.

On the sell side, the largest reduction was Synchrony, an estimated $1.46M trimmed.

  • Parus Finance (UK)'s largest Q4 2022 buy was Tesla: 24,938 shares worth $3.07M.
  • Parus Finance (UK) added most to SLB Ltd in Q4 2022, an estimated $6.23M increase.
  • Parus Finance (UK)'s biggest Q4 2022 reduction was Synchrony, cutting an estimated $1.46M.
  • Parus Finance (UK)'s ten largest holdings make up 69% of its $147M portfolio in Q4 2022.
  • Parus Finance (UK) opened 1 new position and closed 0 in Q4 2022.
  • Parus Finance (UK)'s portfolio value rose 28% quarter-over-quarter to $147M.

Based on Parus Finance (UK)'s 13F filing for Q4 2022, filed 13 Feb 2023.